Jazz Pharmaceuticals Plc (JAZZ)
173.83
+0.58
(+0.33%)
USD |
NASDAQ |
Feb 24, 16:00
182.00
+8.17
(+4.70%)
After-Hours: 07:23
Jazz Pharmaceuticals Research and Development Expense (Quarterly) : 198.20M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alkermes Plc | 80.34M |
| Amarin Corp. Plc | 3.320M |
| Medtronic Plc | 722.00M |
| Perrigo Co. Plc | 24.90M |
| STERIS Plc (Ireland) | 29.50M |